Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Kirby

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Journal of Pharmacy and Pharmacology|June 1, 2006
A comparative study of cationic liposome and niosome-based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in miceAnil Vangala, Daniel Kirby, Ida Rosenkrands, et al.
Journal of Laboratory Automation|September 24, 2013
Centrifugo-Magnetophoretic Purification of CD4+ Cells from Whole Blood Toward Future HIV/AIDS Point-of-Care ApplicationsMacdara Glynn, Daniel Kirby, Danielle Chung, et al.
Journal of Liposome Research|June 12, 2009
Liposome-based cationic adjuvant formulations (CAF): past, present, and futureDennis Christensen, Else Marie Agger, Lars Vibe Andreasen, et al.
Infection|October 10, 2018
A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adultsMicha Loebermann, Carlos Fritzsche, Hilte Geerdes-Fenge, et al.
Scientific Reports|November 11, 2015
A Holistic Multi Evidence Approach to Study the Fragmentation Behaviour of Crystalline MannitolJasdip S Koner, Ali Rajabi-Siahboomi, James Bowen, et al.
Expert Opinion on Drug Delivery|August 7, 2019
Liposomes: a promising carrier for respiratory syncytial virus therapeuticsSameer Joshi, Swapnil Bawage, Pooja Tiwari, et al.
Biochimica Et Biophysica Acta|February 12, 2008
alpha,alpha'-trehalose 6,6'-dibehenate in non-phospholipid-based liposomes enables direct interaction with trehalose, offering stability during freeze-dryingDennis Christensen, Daniel Kirby, Camilla Foged, et al.
Biochimica Et Biophysica Acta|December 3, 2005
Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responsesJesper Davidsen, Ida Rosenkrands, Dennis Christensen, et al.
Scientific Reports|August 30, 2019
Conceptualisation, Development, Fabrication and In Vivo Validation of a Novel Disintegration Tester for Orally Disintegrating TabletsJasdip S Koner, Ali R Rajabi-Siahboomi, Shahrzad Missaghi, et al.
Vaccine|January 12, 2011
Influenza A (H1N1) 2009 two-dose immunization of US children: an observer-blinded, randomized, placebo-controlled trialEric Plennevaux, Mark Blatter, Matthew J Cornish, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Pharmacy and Pharmacology|June 1, 2006
A comparative study of cationic liposome and niosome-based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in miceAnil Vangala, Daniel Kirby, Ida Rosenkrands, et al.
Journal of Laboratory Automation|September 24, 2013
Centrifugo-Magnetophoretic Purification of CD4+ Cells from Whole Blood Toward Future HIV/AIDS Point-of-Care ApplicationsMacdara Glynn, Daniel Kirby, Danielle Chung, et al.
Journal of Liposome Research|June 12, 2009
Liposome-based cationic adjuvant formulations (CAF): past, present, and futureDennis Christensen, Else Marie Agger, Lars Vibe Andreasen, et al.
Infection|October 10, 2018
A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adultsMicha Loebermann, Carlos Fritzsche, Hilte Geerdes-Fenge, et al.
Scientific Reports|November 11, 2015
A Holistic Multi Evidence Approach to Study the Fragmentation Behaviour of Crystalline MannitolJasdip S Koner, Ali Rajabi-Siahboomi, James Bowen, et al.
Expert Opinion on Drug Delivery|August 7, 2019
Liposomes: a promising carrier for respiratory syncytial virus therapeuticsSameer Joshi, Swapnil Bawage, Pooja Tiwari, et al.
Biochimica Et Biophysica Acta|February 12, 2008
alpha,alpha'-trehalose 6,6'-dibehenate in non-phospholipid-based liposomes enables direct interaction with trehalose, offering stability during freeze-dryingDennis Christensen, Daniel Kirby, Camilla Foged, et al.
Biochimica Et Biophysica Acta|December 3, 2005
Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responsesJesper Davidsen, Ida Rosenkrands, Dennis Christensen, et al.
Scientific Reports|August 30, 2019
Conceptualisation, Development, Fabrication and In Vivo Validation of a Novel Disintegration Tester for Orally Disintegrating TabletsJasdip S Koner, Ali R Rajabi-Siahboomi, Shahrzad Missaghi, et al.
Vaccine|January 12, 2011
Influenza A (H1N1) 2009 two-dose immunization of US children: an observer-blinded, randomized, placebo-controlled trialEric Plennevaux, Mark Blatter, Matthew J Cornish, et al.
Pageof 3